Erasca (ERAS) Current Leases (2020 - 2026)
Erasca (ERAS) posted Current Leases of $5.3 million for Q1 2026, up 3.65% on a QoQ basis from $5.1 million in Q4 2025, and up 9.6% year-over-year from $4.8 million in Q1 2025.
Erasca (ERAS) Current Leases (2020 - 2026) Analysis & Trends
Erasca's Current Leases history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- Quarterly Current Leases rose 9.6% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 9.6% YoY) and the FY2025 annual result came in at $5.1 million, up 9.68% from the prior year.
- Current Leases was $5.3 million for Q1 2026 at Erasca, up from $5.1 million in the prior quarter.
- Across five years, Current Leases topped out at $5.3 million in Q1 2026 and bottomed at $14000.0 in Q1 2022.
- A 5-year average of $3.5 million and a median of $4.1 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases sank 77.36% — and 2023, when it soared 22171.43%.
- Erasca's Current Leases stood at $1.3 million in 2022, then soared by 204.21% to $4.0 million in 2023, then advanced by 16.35% to $4.6 million in 2024, then gained by 9.68% to $5.1 million in 2025, then advanced by 3.65% to $5.3 million in 2026.
- Business Quant data shows ERAS's Current Leases at $5.3 million in Q1 2026, $5.1 million in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.82 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | 864,000.00 |
| Jun 30, 2021 | 888,000.00 |